| NCT ID | NCT05434026 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Friendship Hospital |
| Condition | Colonic Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200,000 participants |
| Start Date | 2022-08-03 |
| Primary Completion | 2032-06-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200,000 participants in total. It began in 2022-08-03 with a primary completion date of 2032-06-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
1. To establish the Chinese people's own clinical data database of colorectal cancer, reflecting the law and characteristics of colorectal cancer patients in China. 2. Based on colorectal cancer surgery, collect clinical data, especially data on clinical manifestations, complications, laboratory tests, auxiliary examinations, postoperative clinical effects, surgical complications, and colorectal cancer recurrence, so as to lead the direction of clinical practice and academic research of colorectal cancer surgery in China. It provides a certain basis for future research on colorectal cancer. 3. Provide academic consultation and data support to national health authorities.
Eligibility Criteria
Inclusion Criteria: * adenocarcinoma of the colon by biopsy * tolerable to surgery * be able to understand and willing to participate in this trial with signature Exclusion Criteria: * can not tolerate the surgery * history of serious mental illness * the researchers believe the patients should not enrolled in
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05434026 clinical trial?
This trial is open to participants of all sexes, studying Colonic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05434026 currently recruiting?
Yes, NCT05434026 is actively recruiting participants. Contact the research team at zhangzht@ccmu.edu.cn for enrollment information.
Where is the NCT05434026 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05434026 clinical trial?
NCT05434026 is sponsored by Beijing Friendship Hospital. The trial plans to enroll 200,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.